Search Results
Mar 17, 2026, 09:15 ET DeepRoute.ai Presents 40B Vision-Language-Action Foundation Model at NVIDIA GTC 2026, Accelerating Autonomous Driving at Scale
vehicles equipped with DeepRoute.ai's autonomous driving systems," Cao said. "The Foundation Model serves as the core cornerstone for DeepRoute.ai's next-generation autonomous driving assistance and functions as a fundamental AI framework for the physical world. This unified architecture enables the system
More news about: DeepRoute.ai
Mar 17, 2026, 09:11 ET RoboSense Driving Ecosystem Deployment with Global Partners at NVIDIA GTC 2026
optimal architecture for next-generation autonomous driving systems. At GTC, WeRide and Pony.ai showcased flagship Robotaxis equipped with this integrated solution, signaling Robosense as an enabler powering the robotaxi shift toward global commercial scale.Powering Next-Gen Consumer EVs In
More news about: RoboSense Technology Co., Ltd.
Mar 17, 2026, 09:11 ET Quarterra Welcomes Residents at Emblem Renata
Quarterra's national Emblem program deploys a programmatic approach that utilizes consistent high-end interior finishes from one Emblem community to the next. Amenity designs and property features such as social rooms and fitness centers also follow a consistent programming approach. The garden-style community's
More news about: Quarterra
Mar 17, 2026, 09:10 ET Cariqa builds momentum into 2026 with new partnerships, expanding a growing European ecosystem of unified pricing, payments and compliance
control over our commercial strategy, while delivering a charging experience that reflects our regional responsibility."Infrastructure for the next phase of EV charging:These partnerships highlight Cariqa's growing role as a direct distribution channel for CPOs, and demonstrate how demand-side
More news about: Cariqa
Mar 17, 2026, 09:07 ET Flexcompute and GlobalFoundries Enable Integrated Design and Simulation on GF Silicon Photonics Platform
high-accuracy 3D electromagnetic simulation within a unified environment, Flexcompute is helping establish a more reliable and scalable foundation for next-generation silicon photonics development.PhotonForge PDK support for the GlobalFoundries silicon photonics technology stack is available now
More news about: FlexCompute Inc.
Mar 17, 2026, 09:07 ET Crowe PR Joins United Partners Network as Its U.S. Partner
the Inc. 5000 list of the fastest-growing privately owned companies in America for three consecutive years. Crowe PR is a division of Crowe Media, a next-generation media ecosystem built for how brands are discovered, trusted and scaled in today's AI- and creator-driven landscape. More information:
More news about: CROWE PR
Mar 17, 2026, 09:06 ET Prendio and BioProcure Appoint Life Sciences Technology Leader Larry Birch as Chief Executive Officer
for the life sciences industry, today announced the appointment of Laurence (Larry) Birch as Chief Executive Officer. Birch will lead the company's next phase of growth as it expands its technology platform and services supporting biotechnology and pharmaceutical companies.
More news about: Prendio-BioProcure
Mar 17, 2026, 09:05 ET TerraPower Isotopes announces cGMP manufacturing facility
innovation company that advances transformative technologies across energy and healthcare. TPI is transforming the fight against cancer by bringing the next generation of isotopes to market, and its actinium-225 is currently being utilized in human clinical trials around the world. This new cGMP Bellwether
More news about: TerraPower Isotopes
Mar 17, 2026, 09:05 ET Veriato Introduces Behavioral Visibility Platform for Insider Risk and Workforce Productivity
2026 /PRNewswire/ -- Veriato, the Behavioral Visibility platform and pioneer in Insider Risk Management (IRM), today announced the launch of its next-generation offering, an all-in-one behavioral intelligence solution designed for organization-wide impact, extending beyond traditional security and
More news about: Veriato
Mar 17, 2026, 09:05 ET Quantifind Advances Agentic Execution, Analyzing 2 Million Entities While Automatically Resolving 90% of Risk Cases - Dramatically Reducing Manual Review and Expanding Risk Decision Capacity
reasoning aligned with Model Risk Management expectations."With over 90% of financial institutions planning to implement agentic AI in the next two years, this is no longer a future bet. It's a competitive requirement. Quantifind's latest enhancements show a clear understanding of what regulated
More news about: Quantifind
Mar 17, 2026, 09:05 ET ICONIX INTERNATIONAL AND REVLON ENTER INTO GLOBAL FRAGRANCE DEAL FOR FIRST-EVER SALT LIFE BRAND FRAGRANCE
chief executive officer of Iconix International. "Fragrance is a natural extension of that connection, and Revlon is the ideal partner to bring this next chapter to life on a global scale."Amber Garrison, President of Fragrances at Revlon, added, "SALT LIFE represents an outdoor lifestyle of freedom
More news about: Revlon; Iconix
Mar 17, 2026, 09:04 ET Conning Releases 2026 Cyber Insurance Focus Study the Increasing Insurability of Cyber Risk
perspective on the developing personal lines segment. It provides a grounded assessment of the market's current trajectory and the forces that will shape its next phase of development.Conning's 2026 Cyber Insurance: The Increasing Insurability of Cyber Risk is available for
More news about: Conning
Mar 17, 2026, 09:02 ET Founders Row Invests in Yough as Greek Yogurt-Powered Frozen Pizza Launches Nationwide at Target
Founders Row, the founder-focused investment platform and creative studio backing the next generation of consumer brands, has announced a strategic investment in
More news about: Founders Row
Mar 17, 2026, 09:02 ET ISPE Announces its 2026 ISPE Europe Annual Conference Keynote Speakers
Biotechnology, CRB Group GmbH. "Its program offers a robust, case‑driven examination of how AI‑enabled decision systems, data‑centric compliance models, and next‑generation facility designs are being operationalized across the product lifecycle. With emerging modalities, sustainability requirements, and evolving
More news about: ISPE
Mar 17, 2026, 09:02 ET The CFO blind spot: 92% still rely on manual efforts to close -- despite the potential to automate
experience and trusted by more than 50% of the Fortune 50, Redwood unleashes human potential so enterprises can focus on innovation, growth and what's next.Media ContactLiz [email protected]
More news about: Redwood Software
Mar 17, 2026, 09:02 ET The CFO blind spot: 92% still rely on manual efforts to close -- despite the potential to automate
experience and trusted by more than 50% of the Fortune 50, Redwood unleashes human potential so enterprises can focus on innovation, growth and what's next.Media ContactLiz [email protected] -
More news about: Redwood Software
Mar 17, 2026, 09:01 ET Co-PSMA data presented at EAU Annual Congress 2026 with manuscript accepted for publication in the European Urology journal
(1.26 vs. 0.48, respectively), difference: 0.78 (95% confidence interval [CI]: 0.52 – 1.04) ratio 2.63 (95% CI: 1.64 – 4.20) (p <0.0001).Next-day imaging with 64Cu-SAR-bisPSMA, compared with 68Ga-PSMA-11, identified a greater number of total lesions (63 vs. 24, respectively).
More news about: Clarity Pharmaceuticals
Mar 17, 2026, 09:01 ET Colgate Optic White Unveils Its Most Advanced Whitening Formula: The New Optic White Pro Series Toothpaste
New and Improved Toothpaste Introduces Innovative ActivShine Technology, Revealing A Next-Level ShineNEW YORK, March 17, 2026 /PRNewswire/ -- Colgate® Optic White®, a leader in oral care and teeth
More news about: Colgate
Mar 17, 2026, 09:00 ET GROWNSY Unveils Its Next Brand Evolution, Reframing Parenting as a Journey of Growth
multimedia:https://www.prnewswire.com/news-releases/grownsy-unveils-its-next-brand-evolution-reframing-parenting-as-a-journey-of-growth-302716019.htmlSOURCE
More news about: GROWNSY
Mar 17, 2026, 09:00 ET Experity Expands Leadership Team to Accelerate the Next Generation of Urgent Care AI
multimedia:https://www.prnewswire.com/news-releases/experity-expands-leadership-team-to-accelerate-the-next-generation-of-urgent-care-ai-302715170.htmlSOURCE
More news about: Experity
Mar 17, 2026, 09:00 ET Endo Tools Therapeutics Receives FDA 510(k) Clearance for Next-Generation endomina® EZFuse system
developers of advanced endoscopic medical devices, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for its next-generation technology, the endomina® EZFuse system. This advancement in the company's suturing platform has been engineered with a more intuitive design
More news about: Endo Tools Therapeutics (ETT)
Mar 17, 2026, 09:00 ET Endo Tools Therapeutics Receives FDA 510(k) Clearance for Next-Generation endomina® EZFuse system
developers of advanced endoscopic medical devices, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for its next-generation technology, the endomina® EZFuse system. This advancement in the company's suturing platform has been engineered with a more intuitive design
More news about: Endo Tools Therapeutics (ETT)
Mar 17, 2026, 09:00 ET ADDF Launches New Phase of $150 Million Diagnostics Accelerator Initiative to Power Next Generation of Alzheimer's Precision Medicine Worldwide
in funding, bringing the initiative's total to $150 million. Building on its transformative impact in blood-based diagnostics, the DxA's next phase will advance next-generation biomarkers designed to accelerate drug development, enable combination therapies, and usher in a new era of precision medicine
More news about: Alzheimer's Drug Discovery Foundation
Mar 17, 2026, 09:00 ET Apertura Gene Therapy and Viralgen Announce Strategic Collaboration to Manufacture TfR1 CapX, a Next-Generation Capsid for Gene Therapies Designed to Treat Central Nervous System Diseases
expanding its potential to treat serious neurological and genetic diseases. Apertura has licensed its next-generation capsids to multiple partners, with programs expected to enter clinical trials this year and next year. Founded in 2021 on technology from the Broad Institute and supported by Deerfield Management
More news about: Viralgen
Mar 17, 2026, 09:00 ET Apertura Gene Therapy and Viralgen Announce Strategic Collaboration to Manufacture TfR1 CapX, a Next-Generation Capsid for Gene Therapies Designed to Treat Central Nervous System Diseases
expanding its potential to treat serious neurological and genetic diseases. Apertura has licensed its next-generation capsids to multiple partners, with programs expected to enter clinical trials this year and next year. Founded in 2021 on technology from the Broad Institute and supported by Deerfield Management
More news about: Viralgen